NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, announced today that Robert Taub, Chief Executive Officer, is scheduled to give a company presentation at the Citigroup Small & Mid-Cap Conference on Wednesday, March 19, 2008 at 1:45 p.m. PT (4:45 p.m. ET) at the Four Seasons at Mandalay Bay in Las Vegas.
